Literature DB >> 17184791

Beta3 integrin deficiency promotes cardiac hypertrophy and inflammation.

Jie Ren1, Joan Avery, Haibo Zhao, Jochen G Schneider, F Patrick Ross, Anthony J Muslin.   

Abstract

Cardiac hypertrophy commonly develops in response to pressure overload and is associated with increased mortality. Mechanical stress in the heart can result in the activation of transmembrane integrin alphabeta heterodimers that are expressed in cardiomyocytes. Once activated, integrins stimulate focal adhesion kinase, Grb2, c-src, and other signaling molecules to promote cardiomyocyte growth and gene expression. Mechanical stress can also promote cardiac inflammation that may be mediated, in part, by the activation of integrins expressed in blood-borne cells. To address the role of one integrin, beta(3), in the pathogenesis of cardiac hypertrophy, beta(3)(-/-) mice were examined. beta(3)(-/-) Mice developed moderate spontaneous cardiac hypertrophy associated with systolic and diastolic dysfunction, and these abnormalities were exacerbated by transverse aortic constriction. In addition, beta(3)(-/-) mice developed mild cardiac inflammation with infiltrating macrophages at baseline that was markedly worsened by pressure overload. Bone marrow transplantation experiments showed that blood-borne cells were at least partially responsible for the cardiac hypertrophy and inflammation observed in beta(3)(-/-) mice. These results suggest that alpha(v)beta(3) expression in bone marrow has a generalized suppressive effect on cardiac inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17184791     DOI: 10.1016/j.yjmcc.2006.11.002

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  17 in total

1.  Cell-induced alignment augments twitch force in fibrin gel-based engineered myocardium via gap junction modification.

Authors:  Lauren D Black; Jason D Meyers; Justin S Weinbaum; Yevgeniya A Shvelidze; Robert T Tranquillo
Journal:  Tissue Eng Part A       Date:  2009-10       Impact factor: 3.845

Review 2.  The integrin adhesome: from genes and proteins to human disease.

Authors:  Sabina E Winograd-Katz; Reinhard Fässler; Benjamin Geiger; Kyle R Legate
Journal:  Nat Rev Mol Cell Biol       Date:  2014-04       Impact factor: 94.444

Review 3.  Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern?

Authors:  Xuyang Peng; Laura Pentassuglia; Douglas B Sawyer
Journal:  Circ Res       Date:  2010-04-02       Impact factor: 17.367

4.  Rac1 and RhoA differentially regulate angiotensinogen gene expression in stretched cardiac fibroblasts.

Authors:  Suresh K Verma; Hind Lal; Honey B Golden; Fnu Gerilechaogetu; Manuela Smith; Rakeshwar S Guleria; Donald M Foster; Guangrong Lu; David E Dostal
Journal:  Cardiovasc Res       Date:  2010-12-03       Impact factor: 10.787

5.  Hypertrophic stimulation increases beta-actin dynamics in adult feline cardiomyocytes.

Authors:  Sundaravadivel Balasubramanian; Santhosh K Mani; Harinath Kasiganesan; Catalin C Baicu; Dhandapani Kuppuswamy
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

6.  Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunit.

Authors:  Elizabeth A Morgan; Jochen G Schneider; Timothy E Baroni; Ozge Uluçkan; Emanuela Heller; Michelle A Hurchla; Hongju Deng; Desiree Floyd; Andrew Berdy; Julie L Prior; David Piwnica-Worms; Steven L Teitelbaum; F Patrick Ross; Katherine N Weilbaecher
Journal:  FASEB J       Date:  2009-11-20       Impact factor: 5.191

7.  Beta3 integrin-mediated ubiquitination activates survival signaling during myocardial hypertrophy.

Authors:  Rebecca K Johnston; Sundaravadivel Balasubramanian; Harinath Kasiganesan; Catalin F Baicu; Michael R Zile; Dhandapani Kuppuswamy
Journal:  FASEB J       Date:  2009-04-13       Impact factor: 5.191

8.  Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure.

Authors:  Andrew M Siedlecki; Xiaohua Jin; Anthony J Muslin
Journal:  Kidney Int       Date:  2009-01-21       Impact factor: 10.612

9.  Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis.

Authors:  Eleonora Patsenker; Yury Popov; Felix Stickel; Vreni Schneider; Monika Ledermann; Hans Sägesser; Gerald Niedobitek; Simon L Goodman; Detlef Schuppan
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

10.  β3 integrin in cardiac fibroblast is critical for extracellular matrix accumulation during pressure overload hypertrophy in mouse.

Authors:  Sundaravadivel Balasubramanian; Lakeya Quinones; Harinath Kasiganesan; Yuhua Zhang; Dorea L Pleasant; Kamala P Sundararaj; Michael R Zile; Amy D Bradshaw; Dhandapani Kuppuswamy
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.